Patients allocated to the EC group received Etoposide (60 mg/m 2 ) on days 1 to 5 and carboplatin at an area under the concentration curve of 5 mg/ml/min on day 1 of each cycle.
Etoposide
Etoposide is a chemotherapy medication used as a laboratory reagent. It is a topoisomerase II inhibitor, which means it interferes with the enzyme responsible for uncoiling and replicating DNA. Etoposide is commonly used in research applications to study cell division and DNA replication processes.
Lab products found in correlation
3 protocols using etoposide
Etoposide-Carboplatin with Recombinant Endostatin
Patients allocated to the EC group received Etoposide (60 mg/m 2 ) on days 1 to 5 and carboplatin at an area under the concentration curve of 5 mg/ml/min on day 1 of each cycle.
Antibodies for Flow Cytometric Analysis of PD-1 Expression
Evaluating Cytotoxic and Autophagy Modulators
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!